StreetInsider.com News Articles

Santhera Publishes Agenda for its Annual General Meeting

Tue, 05 May 2026 01:00:00 -0400

Ad hoc announcement pursuant to Art. 53 LR.

Pratteln, Switzerland, May 5, 2026 – Santhera Pharmaceuticals (SIX: SANN) today published the invitation to its Annual General Meeting (AGM), which will be held on May 26, 2026, at 10.00am CEST (doors open at 9:30 am CEST) at the Courtyard Marriott, Hardstrasse 55, 4133 Pratteln, Switzerland.

The invitation to the AGM with agenda items and explanations will be sent to registered shareholders by mail and can be viewed on Santhera’s website at https://www.santhera.com/investors-and-media/investor-toolbox/share-bondholder-meetings

Agenda (Overview)

Approval of the Annual

Santhera Publishes Agenda for its Annual General Meeting

Tue, 05 May 2026 01:00:00 -0400

Ad hoc announcement pursuant to Art. 53 LR.

Agenda (Overview)

Approval of the Annual

Santhera Publishes Agenda for its Annual General Meeting

Tue, 05 May 2026 01:00:00 -0400

Ad hoc announcement pursuant to Art. 53 LR.

Agenda (Overview)

Approval of the Annual

Santhera Publishes Agenda for its Annual General Meeting

Tue, 05 May 2026 01:00:00 -0400

Ad hoc announcement pursuant to Art. 53 LR.

Agenda (Overview)

Approval of the Annual

Santhera Publishes Agenda for its Annual General Meeting

Tue, 05 May 2026 01:00:00 -0400

Ad hoc announcement pursuant to Art. 53 LR.

Agenda (Overview)

Approval of the Annual

Santhera Publishes Agenda for its Annual General Meeting

Tue, 05 May 2026 01:00:00 -0400

Ad hoc announcement pursuant to Art. 53 LR.

Agenda (Overview)

Approval of the Annual

Santhera Publishes Agenda for its Annual General Meeting

Tue, 05 May 2026 01:00:00 -0400

Ad hoc announcement pursuant to Art. 53 LR.

Agenda (Overview)

Approval of the Annual

Santhera Publishes Agenda for its Annual General Meeting

Tue, 05 May 2026 01:00:00 -0400

Ad hoc announcement pursuant to Art. 53 LR.

Agenda (Overview)

Approval of the Annual

Santhera Publishes Agenda for its Annual General Meeting

Tue, 05 May 2026 01:00:00 -0400

Ad hoc announcement pursuant to Art. 53 LR.

Agenda (Overview)

Approval of the Annual

Santhera Publishes Agenda for its Annual General Meeting

Tue, 05 May 2026 01:00:00 -0400

Ad hoc announcement pursuant to Art. 53 LR.

Agenda (Overview)

Approval of the Annual

Santhera Publishes Agenda for its Annual General Meeting

Tue, 05 May 2026 01:00:00 -0400

Ad hoc announcement pursuant to Art. 53 LR.

Agenda (Overview)

Approval of the Annual

Santhera Publishes Agenda for its Annual General Meeting

Tue, 05 May 2026 01:00:00 -0400

Ad hoc announcement pursuant to Art. 53 LR.

Agenda (Overview)

Approval of the Annual

Santhera Publishes Agenda for its Annual General Meeting

Tue, 05 May 2026 01:00:00 -0400

Ad hoc announcement pursuant to Art. 53 LR.

Agenda (Overview)

Approval of the Annual

Santhera Publishes Agenda for its Annual General Meeting

Tue, 05 May 2026 01:00:00 -0400

Ad hoc announcement pursuant to Art. 53 LR.

Agenda (Overview)

Approval of the Annual

Santhera Publishes Agenda for its Annual General Meeting

Tue, 05 May 2026 01:00:00 -0400

Ad hoc announcement pursuant to Art. 53 LR.

Agenda (Overview)

Approval of the Annual

Santhera Publishes Agenda for its Annual General Meeting

Tue, 05 May 2026 01:00:00 -0400

Ad hoc announcement pursuant to Art. 53 LR.

Agenda (Overview)

Approval of the Annual

Santhera Proposes Dr. Srishti Gupta as New Member of the Board of Directors

Thu, 30 Apr 2026 01:00:00 -0400

Ad hoc announcement pursuant to Art. 53 LR.

Pratteln, Switzerland, April 30, 2026 – Santhera Pharmaceuticals (SIX: SANN) proposes to elect Dr. Srishti Gupta, MD, MPP, MPhil, as an Independent Director at the upcoming Annual General Meeting to be held on May 26, 2026.

Thomas Meier, Chairman of the Board, said: “Dr. Gupta has a wealth of experience in building and leading successful businesses, and we are delighted she has agreed to be nominated to join the Board. Her depth of experience as a physician executive, CEO, and board director, combined with her strong track

Santhera Proposes Dr. Srishti Gupta as New Member of the Board of Directors

Thu, 30 Apr 2026 01:00:00 -0400

Ad hoc announcement pursuant to Art. 53 LR.

Pratteln, Switzerland, April 30, 2026 – Santhera Pharmaceuticals (SIX: SANN) proposes to elect Dr. Srishti Gupta, MD, MPP, MPhil, as an Independent Director at the upcoming Annual General Meeting to be held on May 26, 2026.

Thomas Meier, Chairman of the Board, said: “Dr. Gupta has a wealth of experience in building and leading successful businesses, and we are delighted she has agreed to be nominated to join the Board. Her depth of experience as a physician executive, CEO, and board director, combined with her strong track

Santhera Proposes Dr. Srishti Gupta as New Member of the Board of Directors

Thu, 30 Apr 2026 01:00:00 -0400

Ad hoc announcement pursuant to Art. 53 LR.

Pratteln, Switzerland, April 30, 2026 – Santhera Pharmaceuticals (SIX: SANN) proposes to elect Dr. Srishti Gupta, MD, MPP, MPhil, as an Independent Director at the upcoming Annual General Meeting to be held on May 26, 2026.

Thomas Meier, Chairman of the Board, said: “Dr. Gupta has a wealth of experience in building and leading successful businesses, and we are delighted she has agreed to be nominated to join the Board. Her depth of experience as a physician executive, CEO, and board director, combined with her strong track

Santhera Proposes Dr. Srishti Gupta as New Member of the Board of Directors

Thu, 30 Apr 2026 01:00:00 -0400

Ad hoc announcement pursuant to Art. 53 LR.

Pratteln, Switzerland, April 30, 2026 – Santhera Pharmaceuticals (SIX: SANN) proposes to elect Dr. Srishti Gupta, MD, MPP, MPhil, as an Independent Director at the upcoming Annual General Meeting to be held on May 26, 2026.

Thomas Meier, Chairman of the Board, said: “Dr. Gupta has a wealth of experience in building and leading successful businesses, and we are delighted she has agreed to be nominated to join the Board. Her depth of experience as a physician executive, CEO, and board director, combined with her strong track

Santhera Proposes Dr. Srishti Gupta as New Member of the Board of Directors

Thu, 30 Apr 2026 01:00:00 -0400

Ad hoc announcement pursuant to Art. 53 LR.

Pratteln, Switzerland, April 30, 2026 – Santhera Pharmaceuticals (SIX: SANN) proposes to elect Dr. Srishti Gupta, MD, MPP, MPhil, as an Independent Director at the upcoming Annual General Meeting to be held on May 26, 2026.

Thomas Meier, Chairman of the Board, said: “Dr. Gupta has a wealth of experience in building and leading successful businesses, and we are delighted she has agreed to be nominated to join the Board. Her depth of experience as a physician executive, CEO, and board director, combined with her strong track

Santhera Proposes Dr. Srishti Gupta as New Member of the Board of Directors

Thu, 30 Apr 2026 01:00:00 -0400

Ad hoc announcement pursuant to Art. 53 LR.

Pratteln, Switzerland, April 30, 2026 – Santhera Pharmaceuticals (SIX: SANN) proposes to elect Dr. Srishti Gupta, MD, MPP, MPhil, as an Independent Director at the upcoming Annual General Meeting to be held on May 26, 2026.

Thomas Meier, Chairman of the Board, said: “Dr. Gupta has a wealth of experience in building and leading successful businesses, and we are delighted she has agreed to be nominated to join the Board. Her depth of experience as a physician executive, CEO, and board director, combined with her strong track

Santhera Proposes Dr. Srishti Gupta as New Member of the Board of Directors

Thu, 30 Apr 2026 01:00:00 -0400

Ad hoc announcement pursuant to Art. 53 LR.

Pratteln, Switzerland, April 30, 2026 – Santhera Pharmaceuticals (SIX: SANN) proposes to elect Dr. Srishti Gupta, MD, MPP, MPhil, as an Independent Director at the upcoming Annual General Meeting to be held on May 26, 2026.

Thomas Meier, Chairman of the Board, said: “Dr. Gupta has a wealth of experience in building and leading successful businesses, and we are delighted she has agreed to be nominated to join the Board. Her depth of experience as a physician executive, CEO, and board director, combined with her strong track

Santhera Proposes Dr. Srishti Gupta as New Member of the Board of Directors

Thu, 30 Apr 2026 01:00:00 -0400

Ad hoc announcement pursuant to Art. 53 LR.

Pratteln, Switzerland, April 30, 2026 – Santhera Pharmaceuticals (SIX: SANN) proposes to elect Dr. Srishti Gupta, MD, MPP, MPhil, as an Independent Director at the upcoming Annual General Meeting to be held on May 26, 2026.

Thomas Meier, Chairman of the Board, said: “Dr. Gupta has a wealth of experience in building and leading successful businesses, and we are delighted she has agreed to be nominated to join the Board. Her depth of experience as a physician executive, CEO, and board director, combined with her strong track

Santhera Proposes Dr. Srishti Gupta as New Member of the Board of Directors

Thu, 30 Apr 2026 01:00:00 -0400

Ad hoc announcement pursuant to Art. 53 LR.

Pratteln, Switzerland, April 30, 2026 – Santhera Pharmaceuticals (SIX: SANN) proposes to elect Dr. Srishti Gupta, MD, MPP, MPhil, as an Independent Director at the upcoming Annual General Meeting to be held on May 26, 2026.

Thomas Meier, Chairman of the Board, said: “Dr. Gupta has a wealth of experience in building and leading successful businesses, and we are delighted she has agreed to be nominated to join the Board. Her depth of experience as a physician executive, CEO, and board director, combined with her strong track